Intimation of grant of 830050 options under Rossari Employee Stock Option Plan- 2019.

Rossari Biotech's Board meeting on May 27, 2026 approved two items. First, the re-appointment of Ms. Esha Padmanabhan Achan as Non-Executive Independent Director for a second term of 3 years from October 21, 2026 to October 20, 2029, subject to shareholder approval. Second, the Board granted 830,050 stock options to eligible employees under the ESOP 2019 plan at an exercise price of Rs. 537 per option. The options vest over 4 years with 20% each in years 1-3 and 40% in year 4, and can be exercised within 5 years of vesting. If all options are exercised, it would result in 830,050 equity shares of Rs. 2 face value each.